Page last updated: 2024-08-21

indazoles and enmd 2076

indazoles has been researched along with enmd 2076 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, Y; Lyu, J; Miao, Z; Poon, TCW; Shim, JS; Tan, K; Wu, C; Yang, EJ; Zhang, B	1

Other Studies

1 other study(ies) available for indazoles and enmd 2076

Article	Year
PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A. Cancer letters, 2018, 11-01, Volume: 436 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinase A; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; fms-Like Tyrosine Kinase 3; HCT116 Cells; Humans; Indazoles; Mice, Nude; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Signal Transduction; Xenograft Model Antitumor Assays	2018

Article

Year

PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A.

Cancer letters, 2018, 11-01, Volume: 436

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinase A; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; fms-Like Tyrosine Kinase 3; HCT116 Cells; Humans; Indazoles; Mice, Nude; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Signal Transduction; Xenograft Model Antitumor Assays

2018